IL13 and allergic rhinitis: Additionally, H. fusiformis treatment in mouse models challenged with allergic rhinitis inflammation showed anti-inflammatory and anti-allergic effects by suppressing T-helper type 2 cytokine production (IL-13) both locally and systemically; goblet cell hyperplasia OVA-specific IgE formation, and eosinophilic infiltration were all reduced [117].